SGYP

  0%
Previous Close
Open
Price To Book
Market Cap
Shares 0
Volume 0
Short Ratio
Av. Daily Volume 0

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Approval announced January 25, 2018.
Trulance (plecanatide)
Constipation-predominant irritable bowel syndrome (IBS-C)
Approved January 19, 2017.
Trulance (plecanatide)
Chronic idiopathic constipation (CIC)

Latest News

  1. INVESTOR ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Class Action Against Synergy Pharmaceuticals, Inc. (SGYP) and Lead Deadline: April 12, 2019
  2. INVESTOR ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Class Action Against Synergy Pharmaceutical, Inc. (SGYP) and Lead Deadline: April 12, 2019
  3. SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline – SGYP
  4. SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Class Action Against Synergy Pharmaceutical, Inc. (SGYP) and Lead Deadline: April 12, 2019
  5. SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds of Class Action Against Synergy Pharmaceutical, Inc. (SGYP) and Lead Deadline: April 12, 2019
  6. [$$] Synergy Pharma Bankruptcy Plan Cleared for Creditor Poll
  7. SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Announces Class Action Against Synergy Pharmaceutical, Inc. (SGYP) and Lead Plaintiff Deadline: April 12, 2019
  8. Pomerantz Law Firm Announces the Filing of a Class Action on Behalf of Investors in Synergy Pharmaceuticals, Inc. – SGYP
  9. Bausch Health Completes Acquisition Of Certain Assets Of Synergy Pharmaceuticals Inc.
  10. See what the IHS Markit Score report has to say about Synergy Pharmaceuticals Inc.
  11. Chester County to lose 137 pharma jobs
  12. Synergy Pharmaceuticals Receives Court Approval for the Sale of Its Assets to Bausch Health
  13. SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Synergy Pharmaceuticals Inc. - SGYP
  14. The Daily Biotech Pulse: FDA Panel Vote Sinks KaryoPharm, Refuse-To-file Letter For Adamis, Tandem Diabetes Earnings
  15. Bausch Health to Acquire Certain Assets of Synergy Pharmaceuticals Inc.
  16. Synergy Pharmaceuticals Confirms Bausch Health as Successful Bidder for Its Business Assets
  17. [$$] Puerto Rico's Debt Saga May Land Back in Washington's Lap